HKD 2.09
(7.18%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 617 Thousand CNY | -3.62% |
2022 | 565.81 Million CNY | -11.95% |
2021 | 642.61 Million CNY | -29.53% |
2020 | 911.88 Million CNY | 618.45% |
2019 | 126.92 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 118.87 Million CNY | 0.0% |
2024 Q1 | 118.87 Million CNY | -19.2% |
2023 Q4 | 147.12 Million CNY | 351.51% |
2023 FY | 545.34 Million CNY | -3.62% |
2023 Q3 | 32.58 Million CNY | -76.98% |
2023 Q2 | 141.52 Million CNY | 0.0% |
2023 Q1 | 141.52 Million CNY | 15.51% |
2022 Q2 | 201.68 Million CNY | 0.0% |
2022 Q1 | 201.68 Million CNY | -68.73% |
2022 FY | 565.81 Million CNY | -11.95% |
2022 Q4 | 122.52 Million CNY | 0.0% |
2022 Q3 | 122.52 Million CNY | -39.25% |
2021 Q1 | 1.49 Billion CNY | 189.41% |
2021 FY | 642.61 Million CNY | -29.53% |
2021 Q3 | 644.98 Million CNY | -56.99% |
2021 Q4 | 644.98 Million CNY | 0.0% |
2021 Q2 | 1.49 Billion CNY | 0.0% |
2020 FY | 911.88 Million CNY | 618.45% |
2020 Q4 | 518.1 Million CNY | 0.0% |
2020 Q3 | 518.1 Million CNY | 213.77% |
2020 Q2 | 165.12 Million CNY | 0.0% |
2020 Q1 | 165.12 Million CNY | 0.0% |
2019 FY | 126.92 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | 99.81% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 99.917% |